Abstract:Objective To investigate the expression of miR-375 and erb-b2 receptor tyrosine kinase 2 (ERBB2) in epithelial ovarian cancer (EOC) and their relationship with clinicopathological parameters and prognosis.Methods The basic data of 134 EOC patients admitted to The Sixth People's Hospital Affiliated to Shanghai Jiaotong from October 2015 to October 2017 were selected. The expression of miR-375 and ERBB2 in EOC tissues and adjacent normal tissues was determined by real-time quantitative PCR (qRT-PCR), and the relationship between the two index and their clinicopathological features and prognosis was analyzed.Results The expression of miR-375 in EOC tissues was lower than that in adjacent tissues, while the expression of ERBB2 was higher than that in adjacent tissues (all P < 0.05). Both miR-375 and ERBB2 expression were related with FIGO stage and lymph node metastasis (all P <0.05). The expression level of miR-375 in EOC tissues was negatively correlated with the expression level of ERBB2 (P < 0.05). The 3-year overall survival rate of low miR-375 expression group were lower than those of high expression group (P < 0.05). The 3-year overall survival rate of high ERBB2 expression group were lower than those of low expression group (P < 0.05). Cox regression analysis showed that high-level FIGO stage, lymph node metastasis, low miR-375 expression, and high ERBB2 expression were independent risk factors for the prognosis of EOC patients (all P < 0.05).Conclusions The expression of miR-375 is low and ERBB2 is high in EOC. There is a negative correlation between them, and both of them are related to FIGO stage and lymph node metastasis, which have important clinical value in evaluating disease progression and survival rate.